Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report

Ramkissoon, 2021, Overview of therapeutic applications of non-invasive vagus nerve stimulation: a motivation for novel treatments for systemic lupus erythematosus, Bioelectronic Medicine, 7, 8, 10.1186/s42234-021-00069-5 Barber, 2021, Global epidemiology of systemic lupus erythematosus, Nat. Rev. Rheumatol., 17, 515, 10.1038/s41584-021-00668-1 Yacoub Wasef, 2004, Gender differences in systemic lupus erythematosus, Gend. Med., 1, 12, 10.1016/S1550-8579(04)80006-8 Parks, 2017, Understanding the role of environmental factors in the development of systemic lupus erythematosus, Best Pract. Res. Clin. Rheumatol., 31, 306, 10.1016/j.berh.2017.09.005 Ceccarelli, 2015, Genetic factors in systemic lupus erythematosus: contribution to disease phenotype, J Immunol Res, 2015, 10.1155/2015/745647 Mok, 2003, Pathogenesis of systemic lupus erythematosus, J. Clin. Pathol., 56, 481, 10.1136/jcp.56.7.481 Li, 2021, Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus, Front. Immunol., 12 Blanco, 2016, T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis, Eur. J. Immunol., 46, 281, 10.1002/eji.201545760 Karrar, 2018, Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us, Arthritis Rheumatol., 70, 496, 10.1002/art.40396 Ma, 2019, The contribution of macrophages to systemic lupus erythematosus, Clin. Immunol., 207, 1, 10.1016/j.clim.2019.06.009 Nashi, 2010, The role of B cells in lupus pathogenesis, Int. J. Biochem. Cell Biol., 42, 543, 10.1016/j.biocel.2009.10.011 Wise, 2020, Belimumab and Rituximab in systemic lupus erythematosus: a tale of two B cell-targeting agents, Front. Med., 7, 303, 10.3389/fmed.2020.00303 Meirelles Lda, 2009, Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev., 20, 419, 10.1016/j.cytogfr.2009.10.002 Wang, 2017, The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus, Cell. Mol. Immunol., 14, 423, 10.1038/cmi.2015.89 Lu, 2009, Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets, Transpl. Immunol., 22, 55, 10.1016/j.trim.2009.08.002 Wang, 2014, Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study, Arthritis Res. Ther., 16, R79, 10.1186/ar4520 Liang, 2010, Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study, Ann. Rheum. Dis., 69, 1423, 10.1136/ard.2009.123463 Jang, 2016, Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development, Cell Transplant., 25, 1, 10.3727/096368915X688173 Park, 2015, Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus, Cell Transplant., 24, 2367, 10.3727/096368914X685645 Deng, 2017, A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis, Ann. Rheum. Dis., 76, 1436, 10.1136/annrheumdis-2017-211073 Carrion, 2010, Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients, Lupus, 19, 317, 10.1177/0961203309348983 Zhou, 2020, Clinical efficacy and safety of mesenchymal stem cells for systemic lupus erythematosus, Stem Cell. Int., 2020 Li, 2021, An update for mesenchymal stem cell therapy in lupus nephritis, Kidney Dis., 7, 79, 10.1159/000513741 Wang, 2017, Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study, Clin. Exp. Med., 17, 333, 10.1007/s10238-016-0427-0 Sun, 2010, Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus, Arthritis Rheum., 62, 2467, 10.1002/art.27548 Li, 2016, vol. 37 Kern, 2006, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cell., 24, 1294, 10.1634/stemcells.2005-0342 Mohamed-Ahmed, 2018, Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison, Stem Cell Res. Ther., 9, 168, 10.1186/s13287-018-0914-1 Choi, 2012, Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation, Arthritis Rheum., 64, 243, 10.1002/art.33313 Karussis, 2010, Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis, Arch. Neurol., 67, 1187, 10.1001/archneurol.2010.248 Ciccocioppo, 2011, Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease, Gut, 60, 788, 10.1136/gut.2010.214841 Ghoryani, 2019, Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: a successful clinical trial in Iran, Biomed. Pharmacother., 109, 1834, 10.1016/j.biopha.2018.11.056 Li, 2013, Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus, Bone Marrow Transplant., 48, 544, 10.1038/bmt.2012.184